Figure 2From: Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens Overview of the design for the tissue reproducibility validation study. Tissue samples (1-43) were processed in parallel across different sites, pathologists, operators, and RNA isolation kits.Back to article page